drugset / Trial / NCT02655653
Efficacy of Tranexamic Acid and Epsilon-aminocaproic Acid in Reducing Bleeding and Transfusions in Cardiac Surgery
RandomizedParallel-groupTriple-blindSupportive care
Summary
The investigators primary objective is to compare the effectiveness of epsilon-aminocaproic acid (EACA) and tranexamic acid (TA) in reducing bleeding and transfusion in cardiac surgery, with the hypothesis that TA is more effective. The investigators also seek to further examine the clinical benefits and adverse effects profiles of epsilon-aminocaproic acid and tranexamic acid.
Timeline
- Start
- 2008-10
- Primary completion
- 2010-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminocaproic Acid | Small molecule | 15 mg/kg | — |
| Subject | Tranexamic Acid | Small molecule | 16 mg/kg | — |